1) Druker, B. J., Guilhot, F., O'Brien, S. G., et al : Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med, 355 : 2408-2417,2006.
2) Baccarani, M., Cortes, J., Pane, F., et al : Chronic myeloid leukemia : an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol, 27 : 6041-6051,2009.
5) Mahon, F. X., Rea, D., Guilhot, J., et al : Discontinuation of imatinib in patients with chronic myeloid leukemia who have maintenance complete molecular remission for at least 2 years : the prospective, multicenter Stop Imatinib (STIM) trial. Lancet Oncol, 11 : 1029-1035, 2010.